Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Zero-based budgeting effectiveness is supported by statistics showing improved discipline, reduced variances, and better resource use.
15,933 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Pfizer has been a market mover, but recent shifts in demand and patent timelines raise concerns. This guide breaks do...
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
Discover how nyxoah (nyxh) 2025 earnings could shape an investor's view of MedTech plays. This forward-looking analys...
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
Mortgage rates surged to a 3-month high, reshaping the investment landscape. A handful of stocks—mortgage servicers, ...
Oklo’s latest move—acquiring Atomic Alchemy—signals more than a strategic expansion. This article breaks down what it...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...
Bitcoin's renewed drop pulled Strategy, BitMine, and Robinhood shares toward monthly lows. This article breaks down w...
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
Investors noticed a notable move in jumia technologies stock jumped this week as Jumia reported improving early resul...
Is AMD stock still a good buy or is it too late to join the rally? This practical guide breaks down timing, value, an...